Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
TransGenex Nanobiotech Logo
TransGenex Nanobiotech Growth Score
81
CB Rank
1031586
Heat Score
50
TransGenex Nanobiotech is to discover, develop and commercialize nano-scale technologies for novel, cost-effective diagnostic.
Founded
obfuscation
PrivateSeed Tampa, Florida, United States1-10 www.transgenex.com/
Biotechnology
Overview

TransGenex Nanobiotech
Growth Score
81
Heat Score
50

Growth Score81
-3 pts
in past quarter
Heat Score 50
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About TransGenex Nanobiotech

CB Rank
1031586
TransGenex Nanobiotech is to discover, develop and commercialize nano-scale technologies for novel, cost-effective diagnostic.
Founded
obfuscation
PrivateSeed Tampa, Florida, United States1-10 www.transgenex.com/
Biotechnology

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Shyam Mohapatra, Subhra Mohapatra
About the Company
TransGenex Nanobiotech Inc. (TGN), is a Florida-based nanobiotechnology company incorporated in 2004. Their Mission is to discover, develop and commercialize nano-scale technologies for novel, cost-effective diagnostic and therapeutic agents against cancers and other inflammatory diseases.
Phone Number (813)527-1794
Contact Email transgenex@transgenex.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

FiSS4D Cellomics Platform
A platform that uses a synthetic polymer scaffold for 3D and 4D cell culture growth, facilitating cancer research and drug development.
FiSS Tumoroid Discs
Synthetic polymer discs that enable 3D and 4D cell culture growth without the need for customized media.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed
obfuscation
Seed Round - TransGenex Nanobiotech Logo
Seed Round - TransGenex Nanobiotech
1
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 6 Contacts 1

Employee Profiles

News

News and Press

News•Mar 20, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

401

Actively Used Products

6TransGenex Nanobiotech uses 6 technology products and services including HTML5, DigiCert, and  Adobe Fonts, according to G2 Stack.

Active Website Tech Count

3TransGenex Nanobiotech is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Pound Sterling.

Total IP

12The intellectual property of TransGenex Nanobiotech includes 12 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is TransGenex Nanobiotech's headquarters? TransGenex Nanobiotech is located in Tampa, Florida, United States.Who invested in TransGenex Nanobiotech? TransGenex Nanobiotech is funded by Florida Institute for the Commercialization of Florida Technology.When was the last funding round for TransGenex Nanobiotech? TransGenex Nanobiotech closed its last funding round on
obfuscation
from a Seed round.Who are TransGenex Nanobiotech's competitors? Alternatives and possible competitors to TransGenex Nanobiotech may include Emulate, InSphero, and  Sartorius.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|